- Autologous stem-cell-based gene therapy underpins massive revenue potential; advancements in stem cell banking services to support next-gen therapies
- Massive funding for stem cell research in North America propelling substantial revenue potential in stem cells market
ALBANY, N.Y., March 31, 2022 /PRNewswire/ -- Expanding research on stem cells biologics has opened several new frontiers in the treatment of neurological disorders, cancer, heart diseases, and diabetes. Increasing utilization of stem cell culturing media and advancements in harvesting methods have expanded the potential applications of stem cells. The stem cells market is projected to reach valuation of US$ 25.68 Bn by 2028.
Growing number of clinical studies in stem cell-based regenerative medicine are creating value-grab opportunities for pharmaceutical companies, assert the analysts in the TMR study on the stem cells market. Advancements in multipotent haematopoietic stem cell (HSC) transplantation have extended the avenue. Characterization of human embryonic stem cells is enriching the value chain of the stem cells market, since they have emerged as a promising source of regenerative medicine.
Request Brochure of Stem Cells Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=132
Autologous stem-cell-based gene therapies hold promise for inherited disorders. These are gaining preference over allogeneic stem cell transplantation in some blood-specific diseases.
Key Findings of Stem Cells Market Study
- Companies Harnessing Stem Cells in Regenerative Medicine for Numerous Diseases: The potential of stem cells in regenerative medicine has expanded considerably, pivoting on the back of a growing array of preclinical and clinical therapies. Human embryonic stem cells and induced pluripotent stem cells are proved to be promising candidate for therapeutic use in regenerative medicine in various diseases. Cardiovascular regenerative therapies are a case in point. The regenerative medicines segment held a leading share of the global stem cells market in 2020, finds the authors of the TMR study.
Request for Analysis of COVID-19 Impact on Stem Cells Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=132
- Growing Government Funding for Stem Cell Research Spurs Growth: Therapeutics companies have benefitted from the rise in R&D by governments in stem cell research. This has also enriched stem cell banking infrastructure. The demand for stem cell therapies for hematological disorders has been offering lucrative opportunities, concurs the analysts in the stem cells market. A case in point is growing R&D in autologous stem cell-based gene therapies for primary immunodeficiencies (PIDs), congenital forms of cytopenia, and hemoglobinopathies. Gene editing technologies are pivoting the expansion of avenues in the stem cells market.
Stem Cells Market: Key Drivers
- The growing morbidity of chronic diseases is a key driver for strides in stem cell therapies. In particular, the prevalence of cardiovascular disease has been extending the avenue for biotech and pharmaceutical companies in the stem cells market.
- Advancements in manufacturing standards and culture systems ae propelling the prospects of the stem cells market. Of note, expanding stem cell biology, including the exploration of reliable sources of these cells, and harvesting technologies hope for untreatable diseases.
Stem Cells Market: Regional Growth Dynamics
- North America held a major share of the global stem cells market in 2020, and is projected to retain its lead during the forecast period. Extensive research funding by governments and private players on regenerative medicine especially for chronic diseases has spurred revenue gains in the regional market.
- The Asia Pacific stem cells market is estimated to expand at a remarkable growth rate during the forecast period. The growing research spending of pharmaceutical companies on stem cell-based therapies for malignant and non-malignant diseases has bolstered lucrative possibilities, note the in-depth TMR study.
Get Exclusive PDF Sample Copy of Stem Cells Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132
Stem Cells Market: Key Players
Some of the key players in the stem cells market are Caladrius Biosciences, Inc., Osiris Therapeutics, Inc., Cytori Therapeutics, Inc., U.S. Stem Cell, Inc., Takara Bio, Inc., BioTime, Inc., Cellular Engineering Technologies, Inc., and Astellas Pharma, Inc.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=132
Global Stem Cells Market: Segmentation
Stem Cells Market, by Product
- Adult Stem Cell
- Human Embryonic Stem Cell
- Induced Pluripotent Stem Cell
- Others
Stem Cells Market, by Source
- Autologous
- Allogenic
Stem Cells Market, by Application
- Regenerative Medicines
- Neurology
- Oncology
- Cardiology
- Others
- Drug Discovery & Development
Stem Cells Market, by End-user
- Therapeutics Companies
- Cell & Tissue Banks
- Tools & Reagents Companies
- Service Companies
Stem Cells Market, by Region
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- Australia
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- GCC Countries
- Rest of Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:
Human Embryonic Stem Cells Market: The stem cell therapy has garnered immense popularity and is rapidly emerging as one of the most promising areas of research. Recent developments pertaining to the stem cell treatment have paved the way for a plethora of potential therapies due to which, treatments related to human embryonic stem cells are gaining widespread adoption worldwide.
Cancer Stem Cells Market: The rising shift in oncology therapeutics from conventional therapies such as surgeries, chemotherapy, and radiotherapy to stem cell therapies points at expansive growth cancer stem cells market over the 2020 - 2030 forecast period. Over the past couple of years, stem cells have found valuable use for replacement of blood after tumor formation or after tumor treatment.
Synthetic Stem Cells Market: Various types of adult stems cells in regenerative medicines have generated considerable attention and interest among clinicians and the industries at large. There have been a groundswell of interest in stem cell-targeted therapies in cardiology and neurology among researchers. However, the vast therapeutic benefits these have still lack substantial scientific evidence and consistent clinical backing.
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email:sales@transparencymarketresearch.com
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/stem-cells-market.htm
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
